BRIEF-Neovasc says jury found in favor of CardiAQ on relief for contract breach

Thu May 19, 2016 7:54pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 19 (Reuters) - Neovasc Inc

* Jury found in favor of CardiAQ, on claims for relief for breach of contract, breach of duty of honesty in contractual performance

* Says jury awarded $70 million on trade secret claim for relief, and no damages on contractual claims for relief

* Jury issued advisory findings in favor of CardiAQ regarding its causes of action under Massachusetts Gen. Law. Ch. 93A & patent inventorship

* Alexei Marko, Neovasc CEO said will be exploring our options regarding post-trial motions in trial court potentially, appellate process Source text for Eikon: Further company coverage: (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)